Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cytokinetics (CYTK) Depreciation & Amortization (CF) (2016 - 2024)

Historic Depreciation & Amortization (CF) for Cytokinetics (CYTK) over the last 15 years, with Q4 2024 value amounting to $2.4 million.

  • Cytokinetics' Depreciation & Amortization (CF) fell 6238.36% to $2.4 million in Q4 2024 from the same period last year, while for Dec 2024 it was $9.5 million, marking a year-over-year decrease of 1985.37%. This contributed to the annual value of $9.5 million for FY2024, which is 1985.37% down from last year.
  • Latest data reveals that Cytokinetics reported Depreciation & Amortization (CF) of $2.4 million as of Q4 2024, which was down 6238.36% from $2.4 million recorded in Q3 2024.
  • Cytokinetics' Depreciation & Amortization (CF)'s 5-year high stood at $6.3 million during Q4 2023, with a 5-year trough of $408000.0 in Q1 2020.
  • Its 5-year average for Depreciation & Amortization (CF) is $1.6 million, with a median of $1.4 million in 2022.
  • As far as peak fluctuations go, Cytokinetics' Depreciation & Amortization (CF) soared by 28208.69% in 2023, and later tumbled by 6238.36% in 2024.
  • Over the past 5 years, Cytokinetics' Depreciation & Amortization (CF) (Quarter) stood at $471000.0 in 2020, then surged by 55.84% to $734000.0 in 2021, then surged by 125.89% to $1.7 million in 2022, then skyrocketed by 282.09% to $6.3 million in 2023, then tumbled by 62.38% to $2.4 million in 2024.
  • Its Depreciation & Amortization (CF) stands at $2.4 million for Q4 2024, versus $2.4 million for Q3 2024 and $2.4 million for Q2 2024.